These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4910991)

  • 1. [Effect of diuretic treatment on body composition in liver cirrhosis: radioisotope dilution study of the effect of amiloride (MK-870)].
    Quoidbach A; Busset R; Jenny M
    Praxis; 1969 Sep; 58(38):1197-201. PubMed ID: 4910991
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the new diuretic: Amiloride (MK-870)].
    Jenny M
    Praxis; 1969 Sep; 58(38):1192-6. PubMed ID: 5395178
    [No Abstract]   [Full Text] [Related]  

  • 3. [Water and sodium metabolism in non-compensated hepatic cirrhosis: therapeutic indications according to the Arroyo classification].
    Cavatorta F; Queirolo C; Brignole M; Zangani F
    Clin Ter; 1980 Jan; 92(2):143-53. PubMed ID: 7389274
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of diuretic treatment on red cell and plasma sodium concentration in patients with hepatic cirrhosis and ascites.
    Afifi F
    Biomedicine; 1975 Feb; 23(2):68-72. PubMed ID: 1156631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New diuretic with anti-kaliuretic effect in the treatment of cirrhotic ascitis: MK 870(amyloid hydrochlorate). Clinico-humoral study].
    Schmukler B; Bisio S; Iovine E; Cervini BA
    Prensa Med Argent; 1968 Sep; 55(30):1442-6. PubMed ID: 5708468
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.
    Angeli P; Dalla Pria M; De Bei E; Albino G; Caregaro L; Merkel C; Ceolotto G; Gatta A
    Hepatology; 1994 Jan; 19(1):72-9. PubMed ID: 8276370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
    Inoue J; Mori Y; Kawamura T
    Naika; 1969 Nov; 24(5):834-9. PubMed ID: 4902224
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of diuretic therapy on acid-base equilibrium and electrolyte content in patients with liver cirrhosis and ascites].
    Loginov AS; Sakharova TN
    Sov Med; 1976 Dec; (12):53-9. PubMed ID: 1013792
    [No Abstract]   [Full Text] [Related]  

  • 9. [Piretanide in the therapy of water-sodium retention in hepatic cirrhosis].
    Scarpioni L; Crippa G; Zanazzi MA
    G Clin Med; 1982 Jan; 63(1):57-76. PubMed ID: 7106459
    [No Abstract]   [Full Text] [Related]  

  • 10. The physiopathologic basis and limitations of treatment of cirrhotic edema with diuretics retaining potassium.
    Vesin P
    Mater Med Pol; 1974; 6(3):199-201. PubMed ID: 4444335
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the modifications of body composition of the obese during weight reduction].
    Favre H; Busset R; Quoidbach A; Dayer A; Carlier B
    Praxis; 1969 Sep; 58(38):1202-5. PubMed ID: 4901703
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immediate effects of a new diuretic-ethacrynic acid (MK-595)-on the metabolism of sodium, chloride, potassium and water in edematous conditions].
    Mattar E; Cruz HM; Cruz J; de Almeida AL; Cardoso TJ; Rosenbojn J; Laudana AA
    Rev Assoc Med Bras; 1965 Mar; 11(3):73-82. PubMed ID: 5263076
    [No Abstract]   [Full Text] [Related]  

  • 13. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.
    Nguyen-Khac E; Thevenot T; Capron D; Dharancy S; Paupart T; Thabut D; Tiry C
    Eur J Intern Med; 2008 Dec; 19(8):613-8. PubMed ID: 19046728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P
    Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553
    [No Abstract]   [Full Text] [Related]  

  • 15. Compartmentalization of ascites and edema in patients with hepatic cirrhosis.
    Shear L; Ching S; Gabuzda GJ
    N Engl J Med; 1970 Jun; 282(25):1391-6. PubMed ID: 4910836
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of diuretics from the functional viewpoint. 7. Treatment of edema. (2). Treatment of edema and ascites caused by heart failure or liver cirrhosis].
    Furukawa T
    Saishin Igaku; 1965 Jul; 20(7):1743-58. PubMed ID: 5884753
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electrolyte metabolism anomalies in liver cirrhosis].
    Okumura M; Katsuki S
    Saishin Igaku; 1968 Dec; 23(12):2527-33. PubMed ID: 4889816
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of amiloride (MK 870) on water and electrolyte metabolism in ascitic cirrhotics].
    Vesin P; Roberti A; Viguie R
    Schweiz Med Wochenschr; 1969 Jan; 99(1):21-6. PubMed ID: 5790153
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema.
    Sakaida I; Yamashita S; Kobayashi T; Komatsu M; Sakai T; Komorizono Y; Okada M; Okita K;
    J Int Med Res; 2013 Jun; 41(3):835-47. PubMed ID: 23685892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.